Patents by Inventor Ma Luo
Ma Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240112143Abstract: A method of implementing administrative services for managing group feedback is disclosed. A selection of a feedback visibility setting for a feedback message from a plurality of predefined feedback visibility settings is received via a give feedback tab of a user interface. The feedback message and a selection of one or more recipients are received via the give feedback tab. The feedback message is sent to the selected one or more recipients based on the selected feedback visibility setting. A request for feedback and a selection of one or more feedback providers are received via a request feedback tab of the user interface. The request for feedback is sent to the selected one or more feedback providers. Received feedback responses linked to a user profile of the feedback requestor are stored.Type: ApplicationFiled: October 2, 2023Publication date: April 4, 2024Inventors: Eric Koslow, Amy Ming Luo, Byron Sha Yang, Joan Roig, Victor Kmita, Johannes Ma, Elliot Dahl, Adnan Chowdhury, Ricky Rizal Zein, William Michael Dybas, Jack Hanford, Ryan Hinshaw, Jared Erondu, Aleksandr Mistratov, Rahul Rangnekar, Carrie Jo Noonan, Jerry Xie, Nathalie Corinne Bize, Hari Vignesh Ganesan, Audrey Chou, Elise Fung, Jay Ashish Mahabal
-
Publication number: 20240112144Abstract: A method of implementing administrative services for managing status updates is disclosed. A status update configuration window is provided on a graphical user interface. The status update configuration window comprises a plurality of update settings for configuring recurring status updates. A selection of update settings is received in the status update configuration window comprising an update frequency, a set of update questions, and a schedule for update reminders. The selected update settings are stored as an update template. An update summary window is displayed concurrently with the status update configuration window. The update summary window comprises a limited list of one or more selectable update management functions. A selection of an update management function is received from the update summary window.Type: ApplicationFiled: October 2, 2023Publication date: April 4, 2024Inventors: Eric Koslow, Amy Ming Luo, Victor Kmita, Johannes Ma, Ricky Rizal Zein, Joan Roig, Byron Sha Yang, Jack Hanford, Jared Erondu, Elise Fung, Elliot Piersa Dahl, Megan McGowan, Jay Ashish Mahabal, Rahul Rangnekar, William Michael Dybas, Ian William Richard, Nicole Jensen McMullin
-
Patent number: 11813325Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: GrantFiled: June 2, 2022Date of Patent: November 14, 2023Assignee: Her Majesty the Queen in the Right of Canada as Represented by the Minister of HealthInventor: Ma Luo
-
Publication number: 20220313814Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: ApplicationFiled: June 2, 2022Publication date: October 6, 2022Inventor: Ma Luo
-
Patent number: 11389527Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: GrantFiled: March 5, 2020Date of Patent: July 19, 2022Assignee: Her Majesty the Queen in Right of Canada as Represented by the Minister of HealthInventor: Ma Luo
-
Publication number: 20200246269Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: ApplicationFiled: March 5, 2020Publication date: August 6, 2020Inventor: Ma Luo
-
Patent number: 10617645Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: GrantFiled: March 14, 2019Date of Patent: April 14, 2020Inventor: Ma Luo
-
Patent number: 10393905Abstract: A method for torsional wave logging in a borehole of a subterranean formation. The method includes obtaining a torsional wave measurement of the borehole, wherein the torsional wave measurement represents characteristics of a torsional wave propagating within a cylindrical layered structure associated with the borehole, wherein the cylindrical layered structure comprises the subterranean formation and a completion of the borehole, analyzing, by a computer processor, the torsional wave measurement to generate a quality measure of the completion, and displaying the quality measure of the completion.Type: GrantFiled: August 16, 2016Date of Patent: August 27, 2019Assignee: SCHLUMBERGER TECHNOLOGY CORPORATIONInventors: Bikash K. Sinha, Sandip Bose, Jiaqi Yang, Ting Lei, Tarek M. Habashy, Smaine Zeroug, Ma Luo
-
Publication number: 20190201342Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: ApplicationFiled: March 14, 2019Publication date: July 4, 2019Inventor: Ma Luo
-
Patent number: 10285942Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: GrantFiled: April 5, 2012Date of Patent: May 14, 2019Assignee: HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF HEALTHInventor: Ma Luo
-
Publication number: 20180200188Abstract: Instead of generating immune responses to several HIV proteins and risk over activating more CD4+ T cells (easy targets for HIV-1 infection) as current candidate vaccines try to do, a lower magnitude, narrowly focused, well maintained virus specific CD8+ T cell response to multiple subtypes should destroy and eliminate a few founder viruses without inducing inflammatory responses that may activate more CD4+ T cells and provide more targets for HIV-1 virus infection. Specifically, described herein is a method that focuses the immune response to the 12 protease cleavage sites.Type: ApplicationFiled: April 5, 2012Publication date: July 19, 2018Applicant: Her Majesty the Queen in Right of Canada as Repres ented by the Minister of HealthInventor: Ma Luo
-
Publication number: 20160356910Abstract: A method for torsional wave logging in a borehole of a subterranean formation. The method includes obtaining a torsional wave measurement of the borehole, wherein the torsional wave measurement represents characteristics of a torsional wave propagating within a cylindrical layered structure associated with the borehole, wherein the cylindrical layered structure comprises the subterranean formation and a completion of the borehole, analyzing, by a computer processor, the torsional wave measurement to generate a quality measure of the completion, and displaying the quality measure of the completion.Type: ApplicationFiled: August 16, 2016Publication date: December 8, 2016Inventors: BIKASH K. SINHA, SANDIP BOSE, JIAQI YANG, TING LEI, TAREK M. HABASHY, SMAINE ZEROUG, MA LUO
-
Patent number: 9448321Abstract: A method for torsional wave logging in a borehole of a subterranean formation. The method includes obtaining a torsional wave measurement of the borehole, wherein the torsional wave measurement represents characteristics of a torsional wave propagating within a cylindrical layered structure associated with the borehole, wherein the cylindrical layered structure comprises the subterranean formation and a completion of the borehole, analyzing, by a computer processor, the torsional wave measurement to generate a quality measure of the completion, and displaying the quality measure of the completion.Type: GrantFiled: January 4, 2013Date of Patent: September 20, 2016Assignee: SCHLUMBERGER TECHNOLOGY CORPORATIONInventors: Bikash K. Sinha, Sandip Bose, Jiaqi Yang, Ting Lei, Tarek M. Habashy, Smaine Zeroug, Ma Luo
-
Publication number: 20140192619Abstract: A method for torsional wave logging in a borehole of a subterranean formation. The method includes obtaining a torsional wave measurement of the borehole, wherein the torsional wave measurement represents characteristics of a torsional wave propagating within a cylindrical layered structure associated with the borehole, wherein the cylindrical layered structure comprises the subterranean formation and a completion of the borehole, analyzing, by a computer processor, the torsional wave measurement to generate a quality measure of the completion, and displaying the quality measure of the completion.Type: ApplicationFiled: January 4, 2013Publication date: July 10, 2014Inventors: BIKESH K. SINHA, SANDIP BOSE, JIAQI YANG, TING LEI, TAREK M. HABASHY, SMAINE ZEROUG, MA LUO
-
Publication number: 20090012261Abstract: The present invention describes ways to identify HLA allele-specific epitopes that result from HLA restriction of antigen-specific cellular immune responses. The invention employs a combination of bioinformatics and functional assays to systematically identify and classify CTL mutations to determine correlates of virus-host interactions Peptides representing HLA allele-specific epitopes are provided as well as methods for validating HLA-restricted epitopes and methods for measuring T cell responses.Type: ApplicationFiled: March 19, 2008Publication date: January 8, 2009Inventors: Ma Luo, Frank Plummer, Terry Blake Ball, Christina Semeniuk, Harold Peters, Rupert Capina, Mark Mendoza